GLP-1s as an employee benefit: What HR teams need to know about GLP-1s and reproductive health benefits
Employee health isn't isolated to a single condition; it's interconnected. The way we sleep, eat, move, and manage stress plays a foundational role in our overall health, yet these fundamental lifestyle factors are often overlooked in standard workplace wellbeing strategies.
What we will cover:
Speakers
Eileen Burbidge
Dr Gidon Lieberman
GLP-1 medications are one of the most talked-about developments in health right now, but most workplace benefits strategies haven't caught up yet.
Research from Howden found that:
- More than a quarter of UK employees have used a weight-management drug
- Two fifths of employees think their employer should offer weight-management drugs within their employee benefits
- As a result, 44% of employers are reassessing their healthcare plans altogether
Beyond weight management, GLP-1s are now being used for support with metabolic health, fertility and women's health, reproductive health, and menopause symptoms. For HR leaders, that makes them far more than a lifestyle medication, they're a serious consideration for a comprehensive benefits package and the employee demand is growing.
Join us on 16th July to get up to speed on what GLP-1s actually are, what the evidence says, and what offering them as an employee benefit really means in practice.
We'll cover:
- What GLP-1s are and how they work
- The link between metabolic health and reproductive and hormonal health
- What to consider when evaluating GLP-1s as part of your benefits strategy
- How to approach this with employees in a way that's clinically sound, safe, and sustainable
There will be plenty of time for Q&A, as always.
What we will cover:
Speakers
Eileen Burbidge
Dr Gidon Lieberman
